Abstract

Traditional approaches to the human cochlear nerve have been impeded by its bony encasement deep inside the skull base. We present an innovative, minimally invasive, therapeutic pathway for direct access to the nerve to deliver novel regenerative therapies. Neuroanatomical studies on 10 cadaveric human temporal bones were undertaken to identify a potentially safe therapeutic pathway to the cochlear nerve. Simulations based on three-dimensional delineation of anatomical structures obtained from synchrotron phase-contrast imaging were analyzed. This enabled the identification of an approach to the nerve in the fundus of the internal auditory meatus by trephining the medial modiolar wall of the cochlea via the round window for a median depth of 1.48 mm (range 1.21–1.91 mm). The anatomical access was validated on 9 additional human temporal bones using radio-opaque markers and contrast injection with micro-computed tomography surveillance. We thus created an effective conduit for the delivery of therapeutic agents to the cochlear nerve.

Details

Title
A novel therapeutic pathway to the human cochlear nerve
Author
Li, Hao 1 ; Agrawal, Sumit 2 ; Zhu, Ning 3 ; Cacciabue, Daniela I. 4 ; Rivolta, Marcelo N. 4 ; Hartley, Douglas E. H. 5 ; Jiang, Dan 6 ; Ladak, Hanif M. 2 ; O’Donoghue, Gerard M. 7 ; Rask‑Andersen, Helge 1   VIAFID ORCID Logo 

 Uppsala University, Department of Surgical Sciences, Otorhinolaryngology and Head and Neck Surgery, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457) 
 Western University, Department of Otolaryngology-Head and Neck Surgery, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); Western University, Department of Medical Biophysics, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); Western University, Department of Electrical and Computer Engineering, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); Western University, School of Biomedical Engineering, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884) 
 Canadian Light Source, Saskatoon, Canada (GRID:grid.423571.6) (ISNI:0000 0004 0443 7584); University of Saskatchewan, Department of Chemical and Biological Engineering, College of Engineering, Saskatoon, Canada (GRID:grid.25152.31) (ISNI:0000 0001 2154 235X) 
 University of Sheffield, Centre for Stem Cell Biology, School of Biosciences, Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262); University of Sheffield, Neuroscience Institute, Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262) 
 National Institute for Health Research (NIHR), Nottingham Biomedical Research Centre, Nottingham, UK (GRID:grid.511312.5) (ISNI:0000 0004 9032 5393); Nottingham University Hospitals NHS Trust, Queens Medical Centre, Nottingham, UK (GRID:grid.240404.6) (ISNI:0000 0001 0440 1889); University of Nottingham, Otology and Hearing Group, Division of Clinical Neuroscience, School of Medicine, Nottingham, UK (GRID:grid.4563.4) (ISNI:0000 0004 1936 8868) 
 King’s College London, Centre for Craniofacial and Regenerative Biology, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764); Guy’s and St. Thomas’ NHS Foundation Trust, Hearing Implant Centre, London, UK (GRID:grid.420545.2) 
 National Institute for Health Research (NIHR), Nottingham Biomedical Research Centre, Nottingham, UK (GRID:grid.511312.5) (ISNI:0000 0004 9032 5393); Nottingham University Hospitals NHS Trust, Queens Medical Centre, Nottingham, UK (GRID:grid.240404.6) (ISNI:0000 0001 0440 1889) 
Pages
26795
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3124277614
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.